Catalyst4, Inc., 10% Owner at MapLight Therapeutics, Inc. (MLPT), bought 4,400,000 shares at $11.38 ($50.1M) on 2026-08-14, disclosed to the SEC on 2026-08-18.
Open-market purchase of $50.1M MLPT by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| Filing → |